FDA Inspection 1220819 — Dok Hyun Yoon
The FDA completed an inspection of Dok Hyun Yoon on September 21, 2023 in Songpa District. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 21, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Songpa District (Korea (the Republic of))
Additional Details
Clinical Investigator (CI)